Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|June 12, 2019
Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-AnalysisGwang Hun Jeong, Keum Hwa Lee, Jong Yeob Kim, et al.
Oncotarget|January 20, 2018
3D-cultivation of NSCLC cell lines induce gene expression alterations of key cancer-associated pathways and mimic <i>in-vivo</i> conditionsGabriele Gamerith, Johannes Rainer, Julia M Huber, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Anticancer Research|February 28, 2023
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck CancerSandro M Wagner, Teresa Magnes, Thomas Melchardt, et al.
Plos One|March 26, 2014
Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cellsArno Amann, Marit Zwierzina, Gabriele Gamerith, et al.
Nature Communications|April 20, 2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockadeVictoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, et al.
Oncoimmunology|December 21, 2023
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLCStefan Koeck, Arno Amann, Johan Kern, et al.
European Journal of Clinical Investigation|January 28, 2020
Genetic variations in MicroRNA genes and cancer risk: A field synopsis and meta-analysisJae Hyon Park, Gwang Hun Jeong, Kwang Seob Lee, et al.
Molecular Cancer Therapeutics|July 2, 2009
Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomibJudith Loeffler-Ragg, Doris Mueller, Gabriele Gamerith, et al.
Cancers|November 6, 2019
Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-AnalysisJong Yeob Kim, Keum Hwa Lee, Jeonghyun Kang, et al.
Pageof 4